Exchanges
BSE, NSE
Industry
Pharmaceuticals
Issue
Book building

Glenmark Life Sciences IPO

₹748.50

+3.96% on listing

Listing-day close · NSE · 6 Aug 2021 · issue price ₹720

Glenmark Life Sciences’ ₹1,514 crore IPO was priced at ₹720 a share. It listed on the NSE on 6 Aug 2021 and closed its first day at ₹748.50, up 3.96% on the issue price.

Timeline

  1. Opens
  2. Closes
  3. Allotment
  4. Refunds
  5. Shares in demat
  6. Listing

Issue details

Issue size
₹1,514 Cr
Fresh issue
₹1,060 Cr
Offer for sale
₹454 Cr
Lot size
20 shares
Minimum investment
₹14,400
Face value
₹2
Registrar
Kfin Technologies

Subscription

Glenmark Life Sciences IPO subscription by investor category
CategoryShares offeredTimes subscribed
Total—31.02×

Overall, from the basis of allotment.

Financials and valuation

Market cap (post-issue)
₹8,822 Cr
Promoter holding
100.00% → 87.98%

From the offer documents.

Listing

Listing date
6 Aug 2021
Issue price
₹720
Open
₹750.00
High
₹799.00
Low
₹738.00
Close
₹748.50

Listing day on the NSE. The close was +3.96% on the issue price.

GLS share price today

FAQs

When did the Glenmark Life Sciences IPO open and close?

It opened on 27 Jul 2021 and closed on 29 Jul 2021.

What was the Glenmark Life Sciences IPO price?

The price band was ₹695–720 a share. The final issue price was ₹720.

What is the lot size and minimum investment?

One lot is 20 shares, ₹14,400 at ₹720 a share. Retail investors apply in whole lots.

How much did Glenmark Life Sciences raise?

₹1,514 crore: ₹1,060 crore of new shares and ₹454 crore offered by existing shareholders.

How many times was the Glenmark Life Sciences IPO subscribed?

31.02 times overall.

How did Glenmark Life Sciences list?

It listed on the NSE on 6 Aug 2021 at ₹750.00 and closed the day at ₹748.50, up 3.96% on the ₹720 issue price.

Who is the registrar of the Glenmark Life Sciences IPO?

Kfin Technologies handles the allotment, refunds and credit of shares.

For information only. Not investment advice or a research report.

Full disclaimer

See how an IPO fits your plan

Armor checks every holding against your goals, risk and timeline.

Get the app